<p>It is intended to provide a novel cancer antigen peptide and a cancer vaccine comprising this cancer antigen peptide. A peptide dimer wherein two peptide monomers capable of forming a cancer antigen peptide containing at least one cysteine residue and consisting of from 7 to 30 amino acid residues are bonded to each other via a disulfide bond.</p>